← Leaderboards
Xiaoxi Yao
Mayo Clinic Rochester
$1,382,021
Attributed
$2,764,041
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $525.9K · FY2017–24$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,764,041 · 2
By mechanism
R01$2,508,437 · 1
R21$255,604 · 1
Top collaborators
- Peter A Noseworthy7 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Jyotishman Pathak$11,987,741
- Peter A Noseworthy$1,382,021
- Douglas L Packer$4,389,614
- William Karl Thompson$815,481
- Jennifer Lynn St Sauver$8,545,756
Others in their field
Other Emerging Leaders on “Collaborations”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$354,010,808
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$242,102,241
- Lynn Briscoe · Leidos Biomedical Research, Inc.$109,176,575
- Klaus Romero · Critical Path Institute$86,053,372
Research focus
CollaborationsEvaluationClinical TrialsLinkAtrial FibrillationFaceFuturePharmacotherapyCostCharacteristicsTranslationsStrokeStroke RiskInsurance ClaimsCare DeliveryDecision MakingDesignData SourcesAdministrative DatabaseDecision AidEvidence BaseBig DataCognitive LoadComparative Effectiveness Study
Grant awards (7)
Optimizing stroke prevention for older adults with atrial fibrillation: Towards rigorous evaluation and judicious application of a new device$525,861
R01 · FY2024 · AG · contact PI
Optimizing stroke prevention for older adults with atrial fibrillation: Towards rigorous evaluation and judicious application of a new device$525,861
R01 · FY2023 · AG
Optimizing stroke prevention for older adults with atrial fibrillation: Towards rigorous evaluation and judicious application of a new device$488,197
R01 · FY2022 · AG
Optimizing stroke prevention for older adults with atrial fibrillation: Towards rigorous evaluation and judicious application of a new device$493,168
R01 · FY2021 · AG
Optimizing stroke prevention for older adults with atrial fibrillation: Towards rigorous evaluation and judicious application of a new device$475,350
R01 · FY2020 · AG
Pairing Observational and Patient-level Clinical Trial Data to Assess Cardiovascular Risk Reduction with Catheter Ablation for Atrial Fibrillation$127,614
R21 · FY2018 · HL · contact PI
Pairing Observational and Patient-level Clinical Trial Data to Assess Cardiovascular Risk Reduction with Catheter Ablation for Atrial Fibrillation$127,990
R21 · FY2017 · HL · contact PI